These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27504665)

  • 21. Targeted genome modifications in soybean with CRISPR/Cas9.
    Jacobs TB; LaFayette PR; Schmitz RJ; Parrott WA
    BMC Biotechnol; 2015 Mar; 15():16. PubMed ID: 25879861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatment.
    Kennedy EM; Cullen BR
    Virology; 2015 May; 479-480():213-20. PubMed ID: 25759096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR/Cas9-mediated correction of human genetic disease.
    Men K; Duan X; He Z; Yang Y; Yao S; Wei Y
    Sci China Life Sci; 2017 May; 60(5):447-457. PubMed ID: 28534256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in therapeutic CRISPR/Cas9 genome editing.
    Savić N; Schwank G
    Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficiency and Inheritance of Targeted Mutagenesis in Maize Using CRISPR-Cas9.
    Zhu J; Song N; Sun S; Yang W; Zhao H; Song W; Lai J
    J Genet Genomics; 2016 Jan; 43(1):25-36. PubMed ID: 26842991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Practical method for targeted disruption of cilia-related genes by using CRISPR/Cas9-mediated, homology-independent knock-in system.
    Katoh Y; Michisaka S; Nozaki S; Funabashi T; Hirano T; Takei R; Nakayama K
    Mol Biol Cell; 2017 Apr; 28(7):898-906. PubMed ID: 28179459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [CRISPR/Cas9-based genome editing systems and the analysis of targeted genome mutations in plants].
    Ma XL; Liu YG
    Yi Chuan; 2016 Feb; 38(2):118-25. PubMed ID: 26907775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Editing of the Bacillus subtilis Genome by the CRISPR-Cas9 System.
    Altenbuchner J
    Appl Environ Microbiol; 2016 Sep; 82(17):5421-7. PubMed ID: 27342565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Precise in-frame integration of exogenous DNA mediated by CRISPR/Cas9 system in zebrafish.
    Hisano Y; Sakuma T; Nakade S; Ohga R; Ota S; Okamoto H; Yamamoto T; Kawahara A
    Sci Rep; 2015 Mar; 5():8841. PubMed ID: 25740433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One-step generation of triple knockout CHO cell lines using CRISPR/Cas9 and fluorescent enrichment.
    Grav LM; Lee JS; Gerling S; Kallehauge TB; Hansen AH; Kol S; Lee GM; Pedersen LE; Kildegaard HF
    Biotechnol J; 2015 Sep; 10(9):1446-56. PubMed ID: 25864574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Precise gene deletion and replacement using the CRISPR/Cas9 system in human cells.
    Zheng Q; Cai X; Tan MH; Schaffert S; Arnold CP; Gong X; Chen CZ; Huang S
    Biotechniques; 2014; 57(3):115-24. PubMed ID: 25209046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A redesigned CRISPR/Cas9 system for marker-free genome editing in Plasmodium falciparum.
    Lu J; Tong Y; Pan J; Yang Y; Liu Q; Tan X; Zhao S; Qin L; Chen X
    Parasit Vectors; 2016 Apr; 9():198. PubMed ID: 27066899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent Progress in CRISPR/Cas9 Technology.
    Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
    J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Harnessing the native type I-B CRISPR-Cas for genome editing in a polyploid archaeon.
    Cheng F; Gong L; Zhao D; Yang H; Zhou J; Li M; Xiang H
    J Genet Genomics; 2017 Nov; 44(11):541-548. PubMed ID: 29169919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Target Specificity of Cas9 Nuclease via DNA Rearrangement Regulated by the REC2 Domain.
    Sung K; Park J; Kim Y; Lee NK; Kim SK
    J Am Chem Soc; 2018 Jun; 140(25):7778-7781. PubMed ID: 29874063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of sgRNA Off-Target Activity in CRISPR/Cas9 Gene Editing Using Graph Convolution Network.
    Vinodkumar PK; Ozcinar C; Anbarjafari G
    Entropy (Basel); 2021 May; 23(5):. PubMed ID: 34069050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cas9 cleavage assay for pre-screening of sgRNAs using nicking triggered isothermal amplification.
    Zhang K; Deng R; Li Y; Zhang L; Li J
    Chem Sci; 2016 Aug; 7(8):4951-4957. PubMed ID: 30155144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acylation driven by intracellular metabolites in host cells inhibits Cas9 activity used for genome editing.
    Zhao L; You D; Wang T; Zou ZP; Yin BC; Zhou Y; Ye BC
    PNAS Nexus; 2022 Nov; 1(5):pgac277. PubMed ID: 36712324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catalytic Mechanism of Non-Target DNA Cleavage in CRISPR-Cas9 Revealed by
    Casalino L; Nierzwicki Ł; Jinek M; Palermo G
    ACS Catal; 2020 Nov; 10(22):13596-13605. PubMed ID: 33520346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A portable electrochemiluminescence bipolar electrode array for the visualized sensing of Cas9 activity.
    Guo R; Hu S; Wang Z
    Analyst; 2020 May; 145(10):3569-3574. PubMed ID: 32352098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.